Alderley Park hosts key international investment conference


Alderley Park hosts key international investment conference

Delegates from around the world are attending the BioCap conference at the Alderley Park Conference Centre today.

The event brings together international investors and corporate financiers with life science companies seeking funding. Organised by the industry membership group Bionow, it is the only specialist life science investment conference in the North of England and showcases the wealth of life science investment opportunities in the region.

Chris Doherty, managing director of Alderley Park said: “There are over 1,000 life science companies in the North, employing some 38,000 people and making a huge contribution to the UK economy. BioCap is now in its fifth year and has become a major event, where its innovators and the next generation of life science businesses can easily connect.  

“As an organisation Manchester Science Partnerships has a deep understanding of the financial challenges of both starting up and scaling up and actively supports the sector through a number of funds.  We are very pleased that Alderley Park, our flagship life science campus and conference centre has once again been chosen to host the event.”   

Rowena Burns, chief executive of Manchester Science Partnerships, will deliver the keynote address that opens the conference.

The range of investors attending BioCap include Acceleris Capital, Albion Ventures, Amgen, Angel Capital Group, AstraZeneca, Brightstar Partners, Cantor Fitzgerald, Catapult Ventures, Complete Resourcing, Deepbridge Capital, Diagnostic Capital, Edmond De Rothschild Investment Partners, Epidarex Capital, EV Group, Enterprise Ventures, FreeMind Group, Fullbrook Thorpe, Imperial Innovations, Innovate UK, IP Group, Laidlaw & Company, Liberum, Life Science Biznes ConsultingLongbow Capital, London Stock Exchange, Ludlow Wealth Management, Mercia FundManagement, Midven, MVM Life Science Partners, NetScientific, NorthStar Ventures, North West Business Angels, RBS, Seroba, Shore Capital, Spark Impact Ltd, SV Life Sciences, SyndicateRoom, Synergy Health, Tbailey, Wales Business Angel, Warwick Ventures, West Coast Business Angels, Wellcome Trust, WG Partners, Zeus Capital, YFM.